Exenatide-a potential role in treatment of HNF1-alpha MODY in obese patients?
Ahluwalia
R
R
Perkins
K
K
Ewins
D
D
Goenka
N
N
D000328:Adult; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D000077270:Exenatide; D051538:Hepatocyte Nuclear Factor 1-alpha / Q000235:genetics*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008297:Male; D009765:Obesity / Q000150:complications*; D010375:Pedigree; D010455:Peptides / Q000627:therapeutic use*; D014688:Venoms / Q000627:therapeutic use*
D051538:Hepatocyte Nuclear Factor 1-alpha; D007004:Hypoglycemic Agents; D010455:Peptides; D014688:Venoms; D000077270:Exenatide